{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360021393798771584.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.4155/fmc.09.55"}},{"identifier":{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.4155/fmc.09.55"}}],"dc:title":[{"@value":"Designing Photosensitizers for Photodynamic Therapy: Strategies, Challenges and Promising Developments"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380021393798771585","@type":"Researcher","foaf:name":[{"@value":"Martin J Garland"}],"jpcoar:affiliationName":[{"@value":"Lecturer in Pharmaceutics, School of Pharmacy, Queens University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, UK"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393798771586","@type":"Researcher","foaf:name":[{"@value":"Corona M Cassidy"}],"jpcoar:affiliationName":[{"@value":"Lecturer in Pharmaceutics, School of Pharmacy, Queens University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, UK"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393798771584","@type":"Researcher","foaf:name":[{"@value":"David Woolfson"}],"jpcoar:affiliationName":[{"@value":"Lecturer in Pharmaceutics, School of Pharmacy, Queens University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, UK"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393798771587","@type":"Researcher","foaf:name":[{"@value":"Ryan F Donnelly"}],"jpcoar:affiliationName":[{"@value":"Lecturer in Pharmaceutics, School of Pharmacy, Queens University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, UK"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"17568919"},{"@type":"EISSN","@value":"17568927"}],"prism:publicationName":[{"@value":"Future Medicinal Chemistry"}],"dc:publisher":[{"@value":"Informa UK Limited"}],"prism:publicationDate":"2009-07","prism:volume":"1","prism:number":"4","prism:startingPage":"667","prism:endingPage":"691"},"reviewed":"false","url":[{"@id":"https://www.tandfonline.com/doi/pdf/10.4155/fmc.09.55"}],"createdAt":"2009-08-14","modifiedAt":"2024-05-23","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360584340529445632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Styrene Maleic Acid Polymer-Encapsulated Chlorophyll as a Stable Micellar Nanoprobe for Advanced Anticancer Photodynamic Therapy"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.4155/fmc.09.55"},{"@type":"CROSSREF","@value":"10.1021/acsapm.3c02042_references_DOI_935Dw71AS225fjqOFCRol0bNZPy"}]}